“Method Of The Development And Validation For The Determination Of Atorvastatin In Both Bulk And Commercially Pharmaceutical Products” (2022) Journal of Pharmaceutical Negative Results, pp. 5166–5172. doi:10.47750/pnr.2022.13.S09.637.